GD2 A COST CONSEQUENCE ANALYSIS OF A NEW ENDOSCOPIC, INJECTABLE TREATMENT AND EXISTING INTERVENTIONS IN GASTRO-OESOPHAGEAL REFLUX DISEASE
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61576-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)61576-8/fulltext
Section Title :
Section Order :
21
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61576-8&doi=10.1016/S1098-3015(10)61576-8